Partner
CurrentEight Roads is a global proprietary investment firm backed by FidelityServed as a Board Member in a diverse portfolio, including but not limited to:- NeuroSmart, an innovator in digital specialty care infrastructure development for families in China dealing with ASD and ADHD.- Gyenno, which is revolutionizing Parkinson's care through a comprehensive technological approach.- MediTrust, a pioneer in payment innovations tailored to the healthcare sector.- Zeen Health, leading in the provision of digital therapeutics for mental health issues.- EB Tech, an insurtech firm that enhances health insurance services for urban residents.- FCB Health, another insurtech venture, focuses on expanding healthcare coverage to the rural demographic.- Pharbers, a data-driven business intelligence ally for healthcare organizations.- NewTrials, at the forefront of digitalizing clinical trials within China.In addition to these, I have contributed to the growth of other select portfolios including - GST (HKSE: 02273), a leading TCM healthcare service provider in China- Medbanks (HKSE: 00314), a leading medical technology and health management company in China- RareStone Group, dedicated to building the first rare disease ecosystem in China to improve the lives of patients and families impacted by rare diseases with comprehensive and sustainable solutions
